Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Intelgenx Technologies Corp T.IGX

Alternate Symbol(s):  IGXT

Healthcare
IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Company’s film technologies, including VersaFilm, DisinteQ... see more

Recent & Breaking News (TSX:IGX)

IntelGenx Amends Stock Options

GlobeNewswire August 24, 2020

ATAI and IntelGenx enter into Feasibility Agreement to develop pharmaceutical-grade polymeric film technologies for delivery of psychedelic medicines

PR Newswire August 20, 2020

IntelGenx Enters into Feasibility Agreement with ATAI Life Sciences to Develop Pharmaceutical-Grade Polymeric Film-Based Psychedelics

GlobeNewswire August 20, 2020

IntelGenx Reports Second Quarter 2020 Financial Results

GlobeNewswire August 13, 2020

IntelGenx to Report Second Quarter 2020 Financial Results on August 13, 2020 - Conference Call to Follow

GlobeNewswire August 6, 2020

IntelGenx and Tilray® Agree to Amend Certain Exclusivity Terms of Worldwide Cannabis-Infused VersaFilm® Agreement

GlobeNewswire July 20, 2020

IntelGenx Reports Amendment of Stock Option Plan

GlobeNewswire July 15, 2020

IntelGenx and Cybin Corp. Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin Film

GlobeNewswire July 7, 2020

Cybin Corp. and IntelGenx Corp. Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin Film

Business Wire July 7, 2020

IntelGenx Announces Approval of Proposed Amendments to Convertible Debentures

GlobeNewswire June 25, 2020

IntelGenx Provides Update on RIZAPORT® VersaFilm® NDA Resubmission Process Following Type A Meeting with the FDA

GlobeNewswire June 11, 2020

IntelGenx Poised to Launch Hand Sanitizer Business Following Receipt of Health Canada Authorization for Commercial Sale

GlobeNewswire June 10, 2020

IntelGenx Receives Health Canada Cannabis Micro-Processing License

GlobeNewswire June 8, 2020

IntelGenx Announces Intention to Issue Shares in Payment of Principal on Outstanding Debentures, and Meeting of Debentureholders

GlobeNewswire May 28, 2020

IntelGenx Confirms Type A Meeting with the FDA Regarding RIZAPORT® VersaFilm®

GlobeNewswire May 27, 2020

IntelGenx Reports First Quarter 2020 Financial Results

GlobeNewswire May 14, 2020

IntelGenx Announces Intention to Amend Convertible Debentures

GlobeNewswire May 12, 2020

IntelGenx to Report First Quarter 2020 Financial Results on May 14, 2020 - Conference Call to Follow

GlobeNewswire May 8, 2020

IntelGenx Provides Status Update on Cannabis Micro-Processing License Application

GlobeNewswire April 28, 2020

IntelGenx Changes 2020 Annual Meeting of Stockholders to a Virtual-Only Format

GlobeNewswire April 23, 2020